{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:09:52Z","timestamp":1780103392444,"version":"3.54.0"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.juro.2009.10.007","type":"journal-article","created":{"date-parts":[[2009,12,16]],"date-time":"2009-12-16T10:11:57Z","timestamp":1260958317000},"page":"529-533","source":"Crossref","is-referenced-by-count":43,"title":["Performance of Prostate Cancer Prevention Trial Risk Calculator in a Contemporary Cohort Screened for Prostate Cancer and Diagnosed by Extended Prostate Biopsy"],"prefix":"10.1097","volume":"183","author":[{"given":"Carvell T.","family":"Nguyen","sequence":"first","affiliation":[{"name":"Glickman Urological and Kidney Institute and Department of Quantitative Health Sciences (CY, MWK), Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhong","family":"Yu","sequence":"additional","affiliation":[{"name":"Glickman Urological and Kidney Institute and Department of Quantitative Health Sciences (CY, MWK), Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Moussa","sequence":"additional","affiliation":[{"name":"Glickman Urological and Kidney Institute and Department of Quantitative Health Sciences (CY, MWK), Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Kattan","sequence":"additional","affiliation":[{"name":"Glickman Urological and Kidney Institute and Department of Quantitative Health Sciences (CY, MWK), Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Stephen","family":"Jones","sequence":"additional","affiliation":[{"name":"Glickman Urological and Kidney Institute and Department of Quantitative Health Sciences (CY, MWK), Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2009.10.007_bib1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/jnci\/djj131","article-title":"Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial","volume":"98","author":"Thompson","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2009.10.007_bib2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jama.294.1.66","article-title":"Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng\/ml or lower","volume":"294","author":"Thompson","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2009.10.007_bib3","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.urology.2006.10.022","article-title":"External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population","volume":"68","author":"Parekh","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.juro.2009.10.007_bib4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1464-410X.2008.08127.x","article-title":"Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level alone","volume":"103","author":"Hernandez","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2009.10.007_bib5","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0022-5347(05)64667-8","article-title":"Results of the 5 region prostate biopsy method: the repeat biopsy population","volume":"168","author":"Applewhite","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.10.007_bib6","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0090-4295(01)00979-7","article-title":"Importance of posterolateral needle biopsies in the detection of prostate cancer","volume":"57","author":"Epstein","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.juro.2009.10.007_bib7","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/S0022-5347(05)66347-1","article-title":"Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer","volume":"165","author":"Gore","year":"2001","journal-title":"J Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534709026421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534709026421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2009.10.007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T01:48:55Z","timestamp":1651196935000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2009.10.007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["10.1016\/j.juro.2009.10.007"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2009.10.007","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}